ACRIX
Price
$25.42
Change
+$0.06 (+0.24%)
Updated
Dec 24 closing price
Net Assets
1.43B
HSAFX
Price
$9.99
Change
-$0.08 (-0.79%)
Updated
Dec 23 closing price
Net Assets
27.45M
Interact to see
Advertisement

ACRIX vs HSAFX

Header iconACRIX vs HSAFX Comparison
Open Charts ACRIX vs HSAFXBanner chart's image
Horizon Active Risk Assist® I
Price$25.42
Change+$0.06 (+0.24%)
VolumeN/A
Net Assets1.43B
Hussman Strategic Allocation
Price$9.99
Change-$0.08 (-0.79%)
VolumeN/A
Net Assets27.45M
ACRIX vs HSAFX Comparison Chart in %
View a ticker or compare two or three
VS
ACRIX vs. HSAFX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACRIX is a Hold and HSAFX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ACRIX has more cash in the bank: 1.43B vs. HSAFX (27.4M). HSAFX pays higher dividends than ACRIX: HSAFX (2.10) vs ACRIX (0.48). ACRIX was incepted earlier than HSAFX: ACRIX (9 years) vs HSAFX (6 years). HSAFX (2.17) is less costly to investors than ACRIX (1.18). HSAFX is a more actively managed with annual turnover of: 468.00 vs. ACRIX (66.00). HSAFX has a lower initial minimum investment than ACRIX: HSAFX (1000) vs ACRIX (10000000). HSAFX annual gain was more profitable for investors over the last year : 8.67 vs. ACRIX (3.21). ACRIX return over 5 years is better than : 17.05 vs. HSAFX (0.44).
ACRIXHSAFXACRIX / HSAFX
Total Expense Ratio1.181.2991%
Annual Report Gross Expense Ratio1.182.1754%
Fund Existence9 years6 years-
Gain YTD5.4778.18267%
Front LoadN/AN/A-
Min. Initial Investment1000000010001,000,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.43B27.4M5,212%
Annual Yield % from dividends0.482.1023%
Returns for 1 year3.218.6737%
Returns for 3 years27.7210.64261%
Returns for 5 years17.050.443,859%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALMU16.091.21
+8.13%
AELUMA INC
PDD113.441.38
+1.23%
PDD Holdings
XLO0.67N/A
+0.47%
Xilio Therapeutics
ROAD112.010.02
+0.02%
Construction Partners
NABL7.33-0.02
-0.27%
N-able